Participate in polls relating to real-time continuous glucose monitoring and see how your answers relate to your colleagues.
Poll 1, posted 03/25/2022The PROMISE study, published in Diabetes Technology & Therapeutics in February 2022, was completed in order to evaluate:
Poll 2, posted 01/06/2022AID systems provide benefit and may reduce patient's self care burden
Poll 3, posted 12/22/2021As discussed by Dr Forlenza in his presentation, "Novel AID Systems on the Horizon," some forthcoming innovative features are:
Poll 4, posted 11/19/2021As presented by Dr Buckingham, recent clinical trials of a novel automated insulin delivery (AID) system vs. standard therapy (ST) in both adults and children show:
Poll 5, posted 10/22/2021Recent studies of a novel AID system for pediatric and young adults population demonstrated:
Poll 6, posted 09/17/2021From AACE Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus, published 2021
Poll 7, posted 08/25/2021A recent pivotal study of a novel AID system, revealed:
Poll 8, posted 08/20/2021What are device factors to consider when helping your patient select an AID system?
Poll 9, posted 08/19/2021Per Dr Hirsch, core components of Smart Insulin Pens include:
Poll 10, posted 08/05/2021Per Dr Hirsch, smart insulin pens allow patients and providers to see granularity of insulin dosing such as "missed/late doses and calculated dosing to avoid stacking":
Poll 11, posted 07/30/2021Which is correct?
Poll 12, posted 07/22/2021Time-in-range outcomes from a recent clinical study of a novel tubeless AID system revealed:
Poll 13, posted 07/15/2021The use of a bolus calculator feature in novel smart insulin pens benefits people with diabetes by:
Poll 14, posted 06/18/2021Cutting-edge features of a novel Smart Insulin Pen with Advanced Decision support could include which of the following innovations:
Poll 15, posted 06/17/2021Clinical trial of the Omnipod 5 system confirms:
Poll 16, posted 06/10/2021What clinical improvements should be expected from novel AID systems?
Poll 17, posted 06/03/2021Smart Insulin Pen users benefit from individualized digital tools similar to those found in insulin pumps, but with lower cost and the freedom of not being continuously tethered to a pump.
Poll 18, posted 05/25/2021Cohort studies and managed care data analysis of insulin pen usage compared with vial and syringe users, confirm which of the following:
Poll 19, posted 05/20/2021As discussed during Diabetes Technology Roundtable V, recent studies evaluating safety and effectiveness of a tubeless AID system in patients with type 1 diabetes demonstrated:
Poll 20, posted 04/22/2021Clinical trials data and case studies to be presented by Distinguished Faculty on May 6th at the www.cgmEDUCATION.net Diabetes Technology Roundtable V, report which, regarding novel Insulin Pumps and AID systems?
Poll 21, posted 04/01/2021As presented during the DTR IV, Novel AID systems scheduled to be introduced in the near future will have which of the following innovative features?
Poll 22, posted 12/18/2020A June 2020 published article by Dr Hirsch et al on real-world insulin delivery, reports:
Poll 23, posted 11/19/2020As presented during the DTR III, can pump/CGM combinations attain consistent TIR for adults and children?
Poll 24, posted 10/29/2020As presented during the DTR III, 'Pod pumps' are a good fit for older T2s since Medicare will often not approve tubed pumps for this population.
Poll 25, posted 10/09/2020As presented by Dr Diana Isaacs during the DTR II, Glooko Data Uploads show which of the following statistics with respect to Omnipod and CGM users maintaining time in range (TIR 70-180 m/dl) in the US and Canada?
Poll 26, posted 10/02/2020According to Diana Isaacs, PharmD in the Diabetes Technology Roundtable II, and the ADA Standards of Care in Diabetes 2020 guidelines, who can benefit from insulin pump therapy?
Poll 27, posted 09/25/2020According to Dr Gregory Forlenza in the Diabetes Technology Roundtable II, some advantages of using an insulin pump are:
Poll 28, posted 08/06/2020Per a recently published article, onboarding and in-the-moment management via telehealth of a new-onset type 1 diabetes pediatric patient at Barbara Davis Center in Colorado, successfully used which combination of diabetes devices?
Poll 29, posted 07/29/2020A recent article on telemedicine by Drs Garg, Rodbard, Hirsch and Forlenza, concludes which of the following?
Poll 30, posted 06/23/2020While insulin pumps have been used in the United States for more than 30 years, recent statistics estimated which of the following regarding the percentage of patients with Type 2 diabetes utilizing pumps?
Poll 31, posted 06/17/2020Findings from a 3-month, multicenter, retrospective study on Type 2 Diabetes treatment with a tubeless insulin pump, showed:
Poll 32, posted 06/12/2020Which of the following is true regarding Type 2 Diabetes (T2D) treatment with insulin pumps?
Poll 33, posted 06/03/2020Which of the following is true according to the article, Do We Need Updated Guidelines on the Use of Insulin Pump Therapy in Type 2 Diabetes?
Poll 34, posted 04/24/2020Smart insulin pens may have which of the following features:
Poll 35, posted 04/10/2020Which of the following is/are correct as discussed in the article by TS Bailey et al, A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice:
Poll 36, posted 03/11/2020Which of the following feature(s) is/are part of integrated smart insulin pen systems?
Poll 37, posted 02/27/2020According to an article in Medical News Today an observational study from 2015 showed that diabetes patients using insulin pens are:
Poll 38, posted 02/21/2020In 2019, the FDA approved the first Bluetooth enabled insulin pen:
Poll 39, posted 02/14/2020The first insulin pen was introduced in...
Poll 40, posted 02/07/2020The first known mention of diabetes symptoms, frequent urination as a symptom of a mysterious disease that also caused emaciation, was documented in...
Poll 41, posted 01/31/2020What causes insulin resistance and prediabetes, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)?
Poll 42, posted 01/24/2020The HypoDE randomized control trial demonstrated that:
Poll 43, posted 01/17/2020According to the American Diabetes Association, 84 million American adults have prediabetes; how many of them don't know they have it?
Poll 44, posted 12/30/2019The Center for Disease Control (CDC)* released a report on 12.30.19 stating which of the following:
Poll 45, posted 12/19/2019According to a 2005-2016 study of 5,786 US adolescents (aged 12 to 18) and young adults (aged 19 to 34), recently published in JAMA Pediatrics1, which of the following is the emerging health threat that can lead to type 2 diabetes:
Poll 46, posted 11/21/2019In 1916, Boston scientist Elliott Joslin established himself as one of the world's leading diabetes experts by creating the textbook The Treatment of Diabetes Mellitus, which reported which of the following:
Poll 47, posted 10/25/2019Please select the correct statement below.
Poll 48, posted 03/15/2019The I HART CGM study concluded that:
Poll 49, posted 02/14/2019Who can bill for current procedural terminology (CPT) CGM code 95251?
Poll 50, posted 01/31/2019Which one of the following statement(s) is(are) correct of CGM use according to findings from the DIaMonD and GOLD studies:
Poll 51, posted 11/16/2018What are some requirements for CGM as durable medical equipment (DME) to be eligible for Medicare coverage?
Poll 52, posted 11/09/2018With the use of CGM, clinicians are now able to treat their patients differently by:
Poll 53, posted 10/11/2018Which of the following is an important consideration when giving a post-meal insulin bolus with the aid of CGM based trend arrows dosing in order to avoid hypoglycemia in persons using multiple daily insulin therapy?
Poll 54, posted 09/13/2018What are ideal criteria to use continuous glucose monitoring (CGM)?
Poll 55, posted 08/15/2018Real-time continuous glucose monitoring (rtCGM) facilitates our understanding of the relationship between:
Poll 56, posted 07/19/2018Which of the following is true regarding the clinical evidence supporting real-time continuous glucose monitoring (rtCGM) as a standard of care?
Poll 57, posted 05/24/2018The DIaMonD (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) trial found that:
Poll 58, posted 05/03/2018The GOLD trial was notable for providing evidence that:
Poll 59, posted 03/20/2018While wearing CGM, patients should consider:
Poll 60, posted 01/19/2018The DIaMonD (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) Trial found that...
Poll 61, posted 10/26/2017The DIaMonD (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) Trial found that...
Poll 62, posted 09/21/2017The DIaMonD (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) Trial found that...
Poll 63, posted 03/14/2017The best candidates for CGM may include...
Poll 64, posted 01/09/2017Previous studies involving patients with T1D have shown that...
Poll 65, posted 01/05/2017With CGM, what is the role of the pharmacist?
Poll 66, posted 12/06/2016What is most important when evaluating CGM?
Poll 67, posted 11/18/2016In your experience, what have most studies about CGM demonstrated?
Poll 68, posted 06/12/2014What percentage of your patients would benefit from Real-Time CGM?